Reply

Affiliations

Comment

Jonathan Corren. J Allergy Clin Immunol Pract. 2020 Feb.

. 2020 Feb;8(2):822.

doi: 10.1016/j.jaip.2019.11.025.

¹ David Geffen School of Medicine at UCLA, Los Angeles, Calif. Electronic address: jcorren@ucla.edu.

No abstract available

Comment on

Dupilumab Efficacy in Patients with Uncontrolled, Moderate-to-Severe Allergic Asthma.
Corren J, Castro M, O'Riordan T, Hanania NA, Pavord ID, Quirce S, Chipps BE, Wenzel SE, Thangavelu K, Rice MS, Harel S, Jagerschmidt A, Khan AH, Kamat S, Maroni J, Rowe P, Lu Y, Amin N, Pirozzi G, Ruddy M, Graham NMH, Teper A. Corren J, et al. J Allergy Clin Immunol Pract. 2020 Feb;8(2):516-526. doi: 10.1016/j.jaip.2019.08.050. Epub 2019 Sep 12. J Allergy Clin Immunol Pract. 2020. PMID: 31521831 Clinical Trial.
Multiple drug hypersensitivity syndrome (MDH) should not be diagnosed by drug provocation tests.
Jörg L, Yerly D, Pichler W. Jörg L, et al. J Allergy Clin Immunol Pract. 2020 Feb;8(2):822-823. doi: 10.1016/j.jaip.2019.10.050. J Allergy Clin Immunol Pract. 2020. PMID: 32037118 No abstract available.